These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
386 related articles for article (PubMed ID: 1833900)
1. [The hemodynamic profile of amrinone and enoximone in patients with severe heart failure]. Saborowski F; Peters P; Schneider M Z Kardiol; 1991; 80 Suppl 4():63-7. PubMed ID: 1833900 [TBL] [Abstract][Full Text] [Related]
2. [Neurohumoral and hemodynamic effects in combination therapy of enoximone and dopamine]. Mitrovic V; Neuzner J; Opper H; Thormann J; Schlepper M Z Kardiol; 1994; 83 Suppl 2():37-48. PubMed ID: 8091823 [TBL] [Abstract][Full Text] [Related]
3. [Comparison of the hemodynamic effect of enoximone and dopamine in patients after coronary bypass operation]. Birnbaum DE; Preuner JG; Gieseke R; Kasper-König W; Trenk D; Jähnchen E; Dieterich HA Z Kardiol; 1991; 80 Suppl 4():47-52. PubMed ID: 1833897 [TBL] [Abstract][Full Text] [Related]
4. Acute effects of enoximone in chronic heart failure. Saborowski F; Peters P; Schneider M; Fehske W; Dieterich HA J Cardiovasc Pharmacol; 1989; 14 Suppl 1():S57-61. PubMed ID: 2480487 [TBL] [Abstract][Full Text] [Related]
5. [Vasodilatation and positive inotropic effect of the phosphodiesterase inhibitor enoximone]. Holubarsch C; Hasenfuss G; Thierfelder L; Heiss HW; Just H Z Kardiol; 1991; 80 Suppl 4():35-40. PubMed ID: 1833895 [TBL] [Abstract][Full Text] [Related]
6. [Enoximone/dobutamine comparison in chronic congestive cardiac insufficiency with low cardiac output]. Galinier M; Rochiccioli JP; Edouard P; Fourcade J; Massabuau P; Puel J; Fauvel JM; Bounhoure JP Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():27-32. PubMed ID: 2147831 [TBL] [Abstract][Full Text] [Related]
7. Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. Hermiller JB; Leithe ME; Magorien RD; Unverferth DV; Leier CV J Pharmacol Exp Ther; 1984 Feb; 228(2):319-26. PubMed ID: 6694112 [TBL] [Abstract][Full Text] [Related]
8. [Use of enoximone in patients with acute and subacute heart failure in the intensive care unit]. Holubarsch C; Pieske B; Hasenfuss G; Just H Z Kardiol; 1994; 83 Suppl 2():21-5. PubMed ID: 8091821 [TBL] [Abstract][Full Text] [Related]
9. Enoximone (MDL 17,043), a phosphodiesterase inhibitor, in the treatment of advanced, unstable chronic heart failure. Weber KT; Janicki JS; Jain MC J Heart Transplant; 1986; 5(2):105-12. PubMed ID: 2956397 [TBL] [Abstract][Full Text] [Related]
10. [Hemodynamic and clinical effects and treatment tolerance with low-dose iv amrinone in patients with refractory heart failure: a multicenter study. The Group for Research on Amrinone in the Treatment of Refractory Heart Failure]. Dei Cas L; Metra M; Nodari S; Raddino R; Visioli O Cardiologia; 1991 May; 36(5):363-71. PubMed ID: 1756541 [TBL] [Abstract][Full Text] [Related]
11. [The hemodynamic profile of the response to amrinone treatment in severe heart failure]. Domínguez de Rozas J; García Picart J; Guindo Soldevila J; Altimiras Ruiz J; Binia Mizrahi M; Pastor Ramón E; Bayés de Luna A Rev Esp Cardiol; 1991 Apr; 44(4):226-32. PubMed ID: 2068366 [TBL] [Abstract][Full Text] [Related]
12. [Comparison of new cardiac agents using differential therapeutic criteria]. Redmann K; Lunkenheimer PP; Rettig G; Isringhaus H; Flameng W; Demeyere R Z Kardiol; 1991; 80 Suppl 4():7-14. PubMed ID: 1833902 [TBL] [Abstract][Full Text] [Related]
13. [Dose-response relation of intravenous enoximone in congestive cardiac insufficiency]. Lellouche D; Delorme G; Merlet P; Dubois-Randé JL; Duval AM; Tarral A; Bourdarias JP; Vernant P Arch Mal Coeur Vaiss; 1988 Sep; 81(9):1107-13. PubMed ID: 2973777 [TBL] [Abstract][Full Text] [Related]
14. [Effects of R80122. The influence of a new phosphodiesterase inhibitor on global and intestinal hemodynamics in coronary surgery patients]. Lange H; Stephan H; Autschbach R; Lueerssen K; Zielmann S; Sonntag H Anaesthesist; 1992 Aug; 41(8):474-80. PubMed ID: 1524159 [TBL] [Abstract][Full Text] [Related]
15. [Hemodynamics with dobutamine and milrinone in patients with severe heart failure in an intra-individual comparison]. Mager G; Klocke RK; Volkmann A; Kux A; Höpp HW; Hilger HH Z Kardiol; 1991 Feb; 80(2):149-57. PubMed ID: 2058247 [TBL] [Abstract][Full Text] [Related]
16. [Enoximone: hemodynamic effect in patients with cardiac insufficiency]. de Langenhagen B; Bouchoucha H; Scholl JM; Hennetier G; Benacerraf A; Achard F; Bock F Arch Mal Coeur Vaiss; 1990 Sep; 83 Spec No 3():19-25. PubMed ID: 2147830 [TBL] [Abstract][Full Text] [Related]
17. [The dobutamine-dopamine combination versus amrinone in congestive heart failure with a marked edematogenic sign complicated by functional kidney failure. A comparison between 2 different models of inotropic stimulation and diuresis potentiation]. De Vecchis R; Pucciarelli G; Nocerino L; Cocozza M; Setaro A; Torre G; Imperatore F Minerva Cardioangiol; 1998 May; 46(5):163-74. PubMed ID: 9842199 [TBL] [Abstract][Full Text] [Related]
18. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside]. Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922 [TBL] [Abstract][Full Text] [Related]
19. [Acute changes in the hemodynamic profile and circulating levels of atrial natriuretic peptide induced by dobutamine in severe heart failure]. La Vecchia L; Bottero M; Centofante P; Bedogni F; Ometto R; Cera A; Fortunato A G Ital Cardiol; 1996 Aug; 26(8):863-74. PubMed ID: 9005168 [TBL] [Abstract][Full Text] [Related]
20. [Acute effect of enoximone and captopril in patients with heart failure]. Scholz M; Kneissl GD; Dieterich HA; Kaltenbach M; Bussmann WD Z Kardiol; 1991; 80 Suppl 4():69-74. PubMed ID: 1833901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]